BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7529409)

  • 21. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer screening.
    Roetzheim RG; Herold AH
    Prim Care; 1992 Sep; 19(3):637-49. PubMed ID: 1384077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening test for prostate cancer].
    Imai K; Kubota Y; Yamanaka H
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
    Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
    Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical utility of transrectal ultrasound and digital rectal examination in the diagnosis of prostate cancer.
    Shapiro A; Lebensart PD; Pode D; Bloom RA
    Br J Radiol; 1994 Jul; 67(799):668-71. PubMed ID: 8062008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local screening program for prostate cancer].
    Kotsev R; Kolev N; Stratev S; Mikhailov O
    Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
    Philip J; Dutta Roy S; Ballal M; Foster CS; Javlé P
    BJU Int; 2005 May; 95(7):969-71. PubMed ID: 15839915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
    Gosselaar C; Roobol MJ; Roemeling S; Schröder FH
    Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening of cancer of the prostate: study in a Spanish population].
    Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A
    Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer: screening and early detection update.
    Berger NS
    Semin Oncol Nurs; 1993 Aug; 9(3):180-3. PubMed ID: 7692577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and early detection for prostate cancer.
    Magoha GA
    East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A; Shotland Y; Metz Y; Stein A
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for prostate cancer. Comparison of transrectal ultrasound, prostate specific antigen and rectal examination.
    Perrin P; Maquet JH; Bringeon G; Devonec M
    Br J Urol; 1991 Sep; 68(3):263-5. PubMed ID: 1717096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for carcinoma of the prostate: a GP based study.
    Kirby RS; Kirby MG; Feneley MR; McNicholas T; McLean A; Webb JA
    Br J Urol; 1994 Jul; 74(1):64-71. PubMed ID: 7519115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 39. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.
    Coley CM; Barry MJ; Fleming C; Fahs MC; Mulley AG
    Ann Intern Med; 1997 Mar; 126(6):468-79. PubMed ID: 9072935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of transrectal ultrasound (TRUS) in the evaluation of cancer of the prostate.
    Kirkland TA; Lathem JE
    J S C Med Assoc; 1994 May; 90(5):217-9. PubMed ID: 8028292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.